Literature DB >> 22560723

Derivation and characterization of progenitor stem cells from canine allantois and amniotic fluids at the third trimester of gestation.

R A Fernandes1, C V Wenceslau, A L Reginato, I Kerkis, M A Miglino.   

Abstract

Fetal tissues are frequently discarded before (amniocentesis) or after birth, which both facilitates stem cell access and helps to overcome ethical concerns. In the present study, we aimed to isolate and characterize stem cells from the allantoic and amniotic fluids (ALF; AMF) of third trimester canine fetuses. This gestation age has not been previously explored for stem cells isolation. The gestational age, cell culture conditions and method of isolation used in this study allowed for the establishment and efficient expansion of ALF and AMF cells. We showed that the majority of ALF and ALF cells express the stem cell markers, such as vimentin, nestin and cytokeratin 18 (CK18). Under appropriate culture conditions AMF derived cells can undergo differentiation into osteogenic, adipogenic, chondrogenic and neuron-like lineages. ALF derived cells showed adipogenic, and chondrogenic potential. Therefore, ALF and AMF cells derived at the third gestation trimester can be qualified as progenitor stem cells, accordingly referred as (alantoic fluid progenitor/stem) ALF PS cells and (amniotic fluid progenitor/stem) AMF PS cells.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22560723     DOI: 10.1016/j.placenta.2012.03.009

Source DB:  PubMed          Journal:  Placenta        ISSN: 0143-4004            Impact factor:   3.481


  9 in total

Review 1.  Amniotic fluid cells: current progress and emerging challenges in renal regeneration.

Authors:  Stefano Da Sacco; Laura Perin; Sargis Sedrakyan
Journal:  Pediatr Nephrol       Date:  2017-06-15       Impact factor: 3.714

2.  Role of LIN28A in mouse and human trophoblast cell differentiation.

Authors:  Jill L Seabrook; Jeremy D Cantlon; Austin J Cooney; Erin E McWhorter; Brittany A Fromme; Gerrit J Bouma; Russell V Anthony; Quinton A Winger
Journal:  Biol Reprod       Date:  2013-10-24       Impact factor: 4.285

3.  Investigating Optimal Autologous Cellular Platforms for Prenatal or Perinatal Factor VIII Delivery to Treat Hemophilia A.

Authors:  Christopher Stem; Christopher Rodman; Ritu M Ramamurthy; Sunil George; Diane Meares; Andrew Farland; Anthony Atala; Christopher B Doering; H Trent Spencer; Christopher D Porada; Graça Almeida-Porada
Journal:  Front Cell Dev Biol       Date:  2021-08-10

4.  Mesenchymal-like stem cells in canine ovary show high differentiation potential.

Authors:  A B Trindade; J Therrien; J M Garcia; L C Smith
Journal:  Cell Prolif       Date:  2017-10-08       Impact factor: 6.831

5.  Treatment of Hemophilia A in Utero and Postnatally using Sheep as a Model for Cell and Gene Delivery.

Authors:  Christopher D Porada; Graça Almeida-Porada
Journal:  J Genet Syndr Gene Ther       Date:  2012-05-25

Review 6.  Hemophilia A: an ideal disease to correct in utero.

Authors:  Christopher D Porada; Christopher Rodman; Glicerio Ignacio; Anthony Atala; Graça Almeida-Porada
Journal:  Front Pharmacol       Date:  2014-12-11       Impact factor: 5.810

7.  Treatment of Chronic Spinal Cord Injury in Dogs Using Amniotic Membrane-Derived Stem Cells: Preliminary Results.

Authors:  Jéssica Rodrigues Orlandin; Ingrid da Silva Gomes; Shamira de Fátima Sallum Leandro; Artur Fuertes Cagnim; Juliana Barbosa Casals; Adriano Bonfim Carregaro; Silvio Henrique Freitas; Luciana Cristina Machado; Maria Cristina Reis Castiglioni; Ana Liz Garcia Alves; Vânia Maria de Vasconcelos Machado; Carlos Eduardo Ambrósio
Journal:  Stem Cells Cloning       Date:  2021-10-18

8.  Amniotic fluid stem cells from EGFP transgenic mice attenuate hyperoxia-induced acute lung injury.

Authors:  Shih-Tao Wen; Wei Chen; Hsiao-Ling Chen; Cheng-Wei Lai; Chih-Ching Yen; Kun-Hsiung Lee; Shinn-Chih Wu; Chuan-Mu Chen
Journal:  PLoS One       Date:  2013-09-11       Impact factor: 3.240

9.  Cat amniotic membrane multipotent cells are nontumorigenic and are safe for use in cell transplantation.

Authors:  Atanasio S Vidane; Aline F Souza; Rafael V Sampaio; Fabiana F Bressan; Naira C Pieri; Daniele S Martins; Flavio V Meirelles; Maria A Miglino; Carlos E Ambrósio
Journal:  Stem Cells Cloning       Date:  2014-08-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.